Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

PCOS affects nearly 25% of female medical and dental students, impacting their academic and social lives.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

PCOS patients, especially obese ones, often lack vitamin D and may need supplements and lifestyle changes.

PCOS often causes skin issues like excess hair, acne, and hair loss, needing early treatment.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Women with PCOS, especially if they are obese, are more likely to have an underactive thyroid than women without PCOS.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Myo-inositol-based treatments greatly improve pregnancy chances for women with PCOS.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Vitamin D is important for skin health, but more research is needed to understand its full effects and treatment potential.

Adult female acne is complex and requires a combination of treatments for effective management.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.